Ghent University Academic Bibliography

Advanced

An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity

Jessica Wynendaele UGent, Anja Böhnke, Eleonora Leucci, Søren Jensby Nielsen, Irina Lambertz, Stefanie Hammer, Nadja Sbrzesny, Dana Kubitza, Anja Wolf, Elise Gradhand, et al. (2010) CANCER RESEARCH. 70(23). p.9641-9649
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
SURVIVAL, GENE, EXPRESSION, AMPLIFICATION, POLYMORPHISMS, ACCELERATES TUMOR-FORMATION, P53 PATHWAY, BREAST-CANCER, CARCINOMA, TP53 MUTATION
journal title
CANCER RESEARCH
Cancer Res.
volume
70
issue
23
pages
9641 - 9649
Web of Science type
Article
Web of Science id
000285045900014
JCR category
ONCOLOGY
JCR impact factor
8.234 (2010)
JCR rank
12/181 (2010)
JCR quartile
1 (2010)
ISSN
0008-5472
DOI
10.1158/0008-5472.CAN-10-0527
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1101085
handle
http://hdl.handle.net/1854/LU-1101085
date created
2011-01-17 12:20:03
date last changed
2016-12-19 15:45:05
@article{1101085,
  author       = {Wynendaele, Jessica and B{\"o}hnke, Anja and Leucci, Eleonora and Nielsen, S{\o}ren Jensby and Lambertz, Irina and Hammer, Stefanie and Sbrzesny, Nadja and Kubitza, Dana and Wolf, Anja and Gradhand, Elise and Balschun, Katharina and Braicu, Ioana and Sehouli, Jalid and Darb-Esfahani, Silvia and Denkert, Carsten and Thomssen, Christoph and Hauptmann, Steffen and Lund, Anders and Marine, Jean-Christophe and Bartel, Frank},
  issn         = {0008-5472},
  journal      = {CANCER RESEARCH},
  keyword      = {SURVIVAL,GENE,EXPRESSION,AMPLIFICATION,POLYMORPHISMS,ACCELERATES TUMOR-FORMATION,P53 PATHWAY,BREAST-CANCER,CARCINOMA,TP53 MUTATION},
  language     = {eng},
  number       = {23},
  pages        = {9641--9649},
  title        = {An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity},
  url          = {http://dx.doi.org/10.1158/0008-5472.CAN-10-0527},
  volume       = {70},
  year         = {2010},
}

Chicago
Wynendaele, Jessica, Anja Böhnke, Eleonora Leucci, Søren Jensby Nielsen, Irina Lambertz, Stefanie Hammer, Nadja Sbrzesny, et al. 2010. “An Illegitimate microRNA Target Site Within the 3’ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity.” Cancer Research 70 (23): 9641–9649.
APA
Wynendaele, J., Böhnke, A., Leucci, E., Nielsen, S. J., Lambertz, I., Hammer, S., Sbrzesny, N., et al. (2010). An illegitimate microRNA target site within the 3’ UTR of MDM4 affects ovarian cancer progression and chemosensitivity. CANCER RESEARCH, 70(23), 9641–9649.
Vancouver
1.
Wynendaele J, Böhnke A, Leucci E, Nielsen SJ, Lambertz I, Hammer S, et al. An illegitimate microRNA target site within the 3’ UTR of MDM4 affects ovarian cancer progression and chemosensitivity. CANCER RESEARCH. 2010;70(23):9641–9.
MLA
Wynendaele, Jessica, Anja Böhnke, Eleonora Leucci, et al. “An Illegitimate microRNA Target Site Within the 3’ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity.” CANCER RESEARCH 70.23 (2010): 9641–9649. Print.